A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety of combining two agents (everolimus and BKM120) for the
treatment of advanced cancer arising from solid organ in patients who are no longer
benefiting from or unable to withstand standard treatment of these conditions.